department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

masitinib · pharmadog

pharmadog
drugs
masitinib

drug

patient view →

masitinib

Phase 3updated 2mo ago

by AB Science SA

Phase 3

community read0 votes

indications

indications

ALS

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

masitinib [INN]

indication

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

phase

phase_3

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying masitinib

phase3Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosissuspendedn=800
phase3Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patientsnot yet recruitingn=412
phase3Masitinib in Patients With Mild Alzheimer's Diseasenot yet recruitingn=600
phase3Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patientsrecruitingn=495
phase3Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancercompletedn=714
phase3Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)completedn=394
phase3Masitinib in Patients With Mild to Moderate Alzheimer's Diseasecompletedn=721